FDA Clears Taliglucerase Alfa for Kids With Gaucher Disease FDA Clears Taliglucerase Alfa for Kids With Gaucher Disease

Taliglucerase alfa is now indicated for long-term enzyme replacement therapy for children and adults with type 1 Gaucher disease. FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news